Seasonal occurrence and 592 removal of pharmaceutical products in municipal wastewaters, Journal of 593 Environmental Chemical Engineering, vol.2, pp.495-502, 2014. ,
, , p.595, 2012.
, Anthropogenic Metals in Hospital and Urban Wastewater: Its Significance for the 596
, Environment. Bulletin of Environmental Contamination and Toxicology, vol.89, p.1224
Development of a multi-residue analytical 599 methodology based on liquid chromatography-tandem mass spectrometry, 2006. ,
, MS/MS) for screening and trace level determination of pharmaceuticals in surface and 601 wastewaters, Talanta, vol.70, pp.678-690
Occurrence and fate of antibiotic, p.603, 2014. ,
, analgesic/anti-inflammatory, and antifungal compounds in five wastewater treatment 604 processes, Science of the Total Environment, vol.473, pp.235-243
The contribution of pharmaceutically active compounds from healthcare 607 facilities to a receiving sewage treatment plant in canada, Environmental Toxicology, vol.606, pp.850-862, 2016. ,
Occurrence and removal of PPCPs in 610 municipal and hospital wastewaters in Greece, Journal of Hazardous Materials, vol.611, pp.804-817, 2010. ,
Hospital Wastewater 613 Treatment by Membrane Bioreactor: Performance and Efficiency for Organic 614, 2012. ,
, Micropollutant Elimination. Environmental Science & Technology, vol.46, pp.1536-1545
AOX emissions from hospital into 616 municipal wastewater, Chemosphere, vol.36, pp.2437-2445, 1998. ,
Drugs in the environment: emission of drugs, diagnostic aids and 618 disinfectants into wastewater by hospitals in relation to other sources -a review, 2001. ,
, Chemosphere, vol.45, pp.957-969
Impact of of Pharmaceuticals and Personal Care products in hospital effluent and waste water 637 influent/effluent by direct-injection LC-MS-MS, Science of the Total Environment, vol.638, pp.459-478, 2015. ,
Determining the 640 fraction of pharmaceutical residues in wastewater originating from a hospital, Water 641 Research, vol.44, pp.605-615, 2010. ,
Assessing potential modifications to the 643 activated sludge process to improve simultaneous removal of a diverse range of 644 micropollutants, Water Research, vol.62, pp.180-192, 2014. ,
Transformation products of emerging contaminants in the 646 environment and high-resolution mass spectrometry: a new horizon, p.647, 2015. ,
, Bioanalytical Chemistry, vol.407, pp.6257-6273
Fate and distribution of pharmaceuticals in 649 wastewater and sewage sludge of the conventional activated sludge (CAS) and 650 advanced membrane bioreactor (MBR) treatment, Water Research, vol.43, pp.831-841, 2009. ,
, , p.652
Contribution of hospital effluents to the load of 653 pharmaceuticals in urban wastewaters: Identification of ecologically relevant 654 pharmaceuticals, Science of the Total Environment, vol.461, pp.302-316, 2013. ,
Effect of redox 656 conditions on pharmaceutical loss during biological wastewater treatment using 657 sequencing batch reactors, Journal of Hazardous Materials, vol.282, pp.106-115, 2015. ,
Matrix effects: The Achilles heel of quantitative high-performance liquid 659 chromatography-electrospray-tandem mass spectrometry, Clinical Biochemistry, vol.660, pp.328-334, 2005. ,
Fate of antibiotics from hospital and domestic sources in a sewage network, Science of the Total Environment, vol.662, pp.758-766, 2017. ,
Hospital effluents as a source of 665 emerging pollutants: An overview of micropollutants and sustainable treatment 666 options, Journal of Hydrology, vol.389, pp.416-428, 2010. ,
, , p.668, 2012.